LIXT

Lixte Biotechnology Holdings Inc (LIXT)

US
$ 2.175.34%

Price Chart

Key Statistics

Market Cap
$ 1.97M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
12.78K
52W High
$ 3.00
52W Low
$ 0.64
Dividend Yield
0.00%
Beta
0.37

Technicals

50-Day MA
1.2112
200-Day MA
1.654
52 Week High
3
52 Week Low
0.64

About LIXT

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.

Employees
2
Headquarters
Pasadena, CA
CEO
Mr. Bastiaan van der Baan M.Sc.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
NKE
Nike Inc. Common St...
$ 72.10
15.25
SNAP
Snap Inc. Class A C...
$ 8.70
6.88
HIMS
Hims & Hers Health ...
$ 49.36
6.66
BA
Boeing Company (The...
$ 214.20
5.77
CCL
Carnival Corporatio...
$ 27.28
4.16

Top Losers

Symbol/Name
LTP
% Chg
QS
QuantumScape Corpor...
$ 6.62
-13.46
GPMT
Granite Point Mortg...
$ 2.46
-6.11
AEM
Agnico Eagle Mines ...
$ 116.00
-5.73
UAVS
AgEagle Aerial Syst...
$ 1.08
-5.26
PAAS
Pan American Silver...
$ 27.66
-5.05